Back to Browse Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 4

Primary infragenicular angioplasty for diabetic neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the vascular interventionist?

Authors Alexandrescu V, Hubermont G

Published Date August 2011 Volume 2011:4 Pages 327—336

DOI http://dx.doi.org/10.2147/DMSO.S23471

Published 22 August 2011

Vlad Alexandrescu1, Gerard Hubermont2
1Department of Vascular Surgery, Princess Paola Hospital, Marche- en-Famenne, Belgium; 2Department of Diabetology, Princess Paola Hospital, Marche-en-Famenne and Sainte-Thérèse Hospital, Bastogne, Belgium

Abstract: The angiosome principle was first described by Jan Taylor in 1987 in the plastic reconstructive surgery field, providing useful information on the vascular anatomy of the human body. Specifically concerning foot and ankle pathology, it may help the clinician to select better vascular access and specific strategies for revascularization. This knowledge may be particularly beneficial when treating diabetic neuroischemic foot wounds associated with particularly aggressive atherosclerotic disease and a poor collateral circulation. The implementation of angiosome-based strategies in diabetic infragenicular vascular reconstruction may afford encouraging wound healing and limb preservation rates using both bypass and endovascular techniques. The minimal invasiveness of these novel strategies enables us to perform more specific and more distal tibial and/or foot arterial reconstructions, in one or multiple targeted vessels. This paper reviews the available literature on this revascularization strategy and focuses on the potential benefit of angiosome-guided primary angioplasty for diabetic ischemic foot ulcers.

Keywords: critical limb ischemia, diabetic foot, limb salvage, angiosomes, angioplasty

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Navigated focal laser photocoagulation for central serous chorioretinopathy

Chhablani J, Rani PK, Mathai A, Jalali S, Kozak I

Clinical Ophthalmology 2014, 8:1543-1547

Published Date: 18 August 2014

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]

Soosay Raj TA, Smith AM, Moore AS

International Journal of Nanomedicine 2013, 8:4705-4706

Published Date: 5 December 2013

Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus

Zhang Y, Zhou J, Guo D, Ao M, Zheng Y, Wang Z

International Journal of Nanomedicine 2013, 8:3745-3756

Published Date: 1 October 2013

Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation

Yang KY, Hwang DH, Yousaf AM, Kim DW, Shin YJ, Bae ON, Kim YI, Kim JO, Yong CS, Choi HG

International Journal of Nanomedicine 2013, 8:3333-3343

Published Date: 28 August 2013

Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia

de Sousa VP, Crean J, Borges VRA, Rodrigues CR, Tajber L, Boylan F, Cabral LM

International Journal of Nanomedicine 2013, 8:3129-3139

Published Date: 15 August 2013

Predictors and prevention of diabetic cardiomyopathy

Chavali V, Tyagi SC, Mishra PK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:151-160

Published Date: 11 April 2013

Utility of adjunctive macrolide therapy in treatment of children with asthma: a systematic review and meta-analysis

Mikailov A, Kane I, Aronoff SC, Luck R, DelVecchio MT

Journal of Asthma and Allergy 2013, 6:23-29

Published Date: 16 January 2013

Positively charged cholesterol–recombinant human gelatins foster the cellular uptake of proteins and murine immune reactions

Kadengodlu PA, Hebishima T, Takeshima SN, Ito M, Liu M, Abe H, Aida Y, Aigaki T, Ito Y

International Journal of Nanomedicine 2012, 7:5437-5450

Published Date: 11 October 2012